Research workbench
NMR2 Structure of KRAS G12V (GMPPNP bound) in complex with 5-(1H-indol-2-l)piperazin-2-one
Analyse NMR2 Structure of KRAS G12V (GMPPNP bound) in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 8PI0
- Type
- protein
- Length
- 168 residues
- Chains
- 1
- Method
- solution nmr
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- NOT
- Source
- Homo sapiens
- Molecule
- V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, isoform CRA_b
- UniProt
- A0A024RAV5
- Ligands
- YVW
- Pockets
- 5 · best druggability 0.78
Structure
solution nmr · resolution NOT · 1 distinct chain · 37% helix, 23% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, isoform CRA_b | protein | 168 | 37% helix, 23% strand | A0A024RAV5 |
Ligands and binding sites
- YVW · (5~{S})-5-(1~{H}-indol-2-yl)piperazin-2-one · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 103 | 0.78 | 0.97 | 35 | empty |
| 2 | 137 | 0.66 | 0.88 | 28 | YVW |
| 3 | 111 | 0.61 | 0.86 | 32 | empty |
| 4 | 50 | 0.33 | 0.78 | 12 | empty |
| 5 | 53 | 0.33 | 0.78 | 16 | empty |
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A0A024RAV5
- Elsewhere: RCSB PDB 8PI0 · PDBe 8PI0 · UniProt A0A024RAV5
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.